Published in Am J Transplant on July 27, 2011
Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis. BMJ (2015) 1.49
A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients. Am J Transplant (2012) 1.11
Systematic conversion to generic tacrolimus in stable kidney transplant recipients. Clin Kidney J (2014) 0.96
Progress in abdominal organ transplantation. Med Sci Monit (2011) 0.81
Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation. Eur J Hosp Pharm Sci Pract (2013) 0.81
Immunosuppression, generic drugs and the FDA. Am J Transplant (2011) 0.80
Transplant coordinators' perceived impact of availability of multiple generic immunosuppression therapies on patients, workload, and posttransplant maintenance therapy. J Transplant (2013) 0.78
Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients. Transpl Int (2012) 0.77
Response to Klintmalm on the use of generic immunosuppression. Am J Transplant (2011) 0.77
Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored. J Transplant (2017) 0.75
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod. Drug Des Devel Ther (2016) 0.75
Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients. Drug Des Devel Ther (2017) 0.75
A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation. Ther Drug Monit (2017) 0.75
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Shipment of human islets for transplantation. Am J Transplant (2007) 2.01
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology (1993) 1.90
Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg (1982) 1.84
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation (2001) 1.79
Impact of pretransplant renal function on survival after liver transplantation. Transplantation (1995) 1.58
Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression. Am J Transplant (2011) 1.56
Readmission to the intensive care unit after liver transplantation. Crit Care Med (2001) 1.54
Metallic stents for the treatment of intrahepatic biliary strictures after liver transplantation. J Vasc Interv Radiol (1996) 1.51
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant (2014) 1.50
Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (1998) 1.46
De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transpl Surg (1998) 1.42
The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation (1992) 1.41
Effect of pentoxifylline on hepatic ischemia and reperfusion injury. Surgery (1997) 1.41
Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation (1981) 1.38
The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation (1990) 1.37
Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther (1995) 1.33
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant (2011) 1.29
Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients. Transplantation (1991) 1.18
Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis. Transplantation (2001) 1.15
The elderly liver transplant recipient: a call for caution. Ann Surg (2001) 1.15
Results after liver retransplantation (RETx): a comparative study between "elective" vs "nonelective" RETx. Transplant Proc (1990) 1.14
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Aliment Pharmacol Ther (2007) 1.13
Problematic vascular reconstruction in liver transplantation. Part I. Arterial. Surgery (1990) 1.12
RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg (1992) 1.11
Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation (2000) 1.10
Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation (1997) 1.10
Hepatic artery stenosis after liver transplantation--incidence, presentation, treatment, and long term outcome. Transplantation (1997) 1.09
The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet (1993) 1.08
De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients. Am J Transplant (2013) 1.07
Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant (1998) 1.05
Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation (1996) 1.05
Problematic vascular reconstruction in liver transplantation. Part II. Portovenous conduits. Surgery (1990) 1.04
Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg (1997) 1.04
Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc (1985) 1.04
A simple model to estimate survival after retransplantation of the liver. Transplantation (1999) 1.02
Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism. Am J Transplant (2005) 1.02
Late follow-up after thoracic duct drainage in cadaveric renal transplantation. Surg Gynecol Obstet (1981) 1.01
Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr (1996) 1.01
The impact of treatment of portopulmonary hypertension on survival following liver transplantation. Am J Transplant (2007) 1.01
Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology (1999) 1.01
Combined liver-kidney transplantation: what are the indications? Transplantation (1997) 1.00
A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology (1997) 1.00
Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl (2000) 1.00
The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol. Anesthesiology (1999) 1.00
Immune reconstitution with donor-derived memory/effector T cells after orthotopic liver transplantation. Exp Hematol (1997) 0.98
The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant (2014) 0.96
A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation (1990) 0.96
Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation (1998) 0.96
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. Transplantation (1992) 0.95
Bortezomib for acute antibody-mediated rejection in liver transplantation. Am J Transplant (2012) 0.95
99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A. Radiology (1982) 0.95
Liver and kidney transplantation for polycystic disease. Transplantation (1998) 0.94
Cyclosporin A treatment in a case of relapsing polychondritis. Scand J Rheumatol (1984) 0.94
Steps in immunosuppression for renal transplantation. Kidney Int Suppl (1983) 0.93
Transplant center regulations--a mixed blessing? An ASTS Council viewpoint. Am J Transplant (2008) 0.93
Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation (1996) 0.92
Class II alloantibody and mortality in simultaneous liver-kidney transplantation. Am J Transplant (2013) 0.92
An unusual presentation of fulminant hepatic failure secondary to propylthiouracil therapy. Clin Transpl (1989) 0.92
Cannulation of the aorta in organ donors with aortic and caval injuries at the time of procurement. Pediatr Transplant (2001) 0.91
Simultaneous heart and kidney transplantation: a report of three cases and review of the literature. J Heart Lung Transplant (1992) 0.89
Direct measurement of hepatic blood flow in native and transplanted organs, with accompanying systemic hemodynamics. Hepatology (1992) 0.89
Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome. Semin Liver Dis (1992) 0.88
Does intraoperative hepatic artery flow predict arterial complications after liver transplantation? Transplantation (1998) 0.87
Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation (1997) 0.86
Quality of life improvements at one, two, and five years after liver transplantation. Transplantation (1995) 0.86
Simultaneous liver and renal transplantation in man. Transplantation (1988) 0.86
p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons. Carcinogenesis (1996) 0.85
The safety of cardiac operations in the liver transplant recipient. Ann Thorac Surg (1998) 0.85
Baylor update: outcome analysis in liver transplantation. Clin Transpl (1993) 0.85
Survival after liver transplantation in 300 consecutive patients: the influence of age, clinical status, and pretransplant disease. Transplant Proc (1992) 0.85
Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg (1998) 0.85
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. Transplant Proc (1995) 0.85
It is time to re-think 'extended criteria'. Am J Transplant (2006) 0.84
A totally failing liver may be more harmful than no liver at all: three cases of total hepatic devascularization in preparation for emergency liver transplantation. Transplant Proc (1991) 0.83
Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet (1992) 0.82
FK506 conversion for intractable rejection of the liver allograft. Transpl Int (1993) 0.82
Colon carcinoma in patients undergoing liver transplantation. Am J Surg (1998) 0.82
Results after liver retransplantation in a group of 50 regrafted patients: two different concepts of elective versus emergency retransplantation. Transpl Int (1991) 0.81
Recurrence of hepatitis B after liver transplantation: does hepatitis-B-immunoglobulin modify the recurrent disease? Transplant Proc (1990) 0.81
Post-transplant lymphoproliferative syndrome in the pediatric liver transplant population. Am J Transplant (2001) 0.81
Sirolimus conversion after liver transplantation: improvement in measured glomerular filtration rate after 2 years. Transplant Proc (2005) 0.81
The Declaration of Istanbul: review and commentary by the American Society of Transplant Surgeons Ethics Committee and Executive Committee. Am J Transplant (2009) 0.81
Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. Transplant Proc (1991) 0.81
Retrospective evaluation of liver transplantation for cirrhosis: a comparative study of 100 patients with or without previous porto-systemic shunt. Transplant Proc (1991) 0.80
A randomized double-blind study of the effect of prophylactic immune globulin on the incidence and severity of CMV infection in the liver transplant recipient. Transplant Proc (1991) 0.80
FK506-associated thrombotic thrombocytopenic purpura. Transplantation (1993) 0.80
Intraoperative measurements related to subsequent hepatic graft failure. Transplant Proc (1989) 0.80
Microsatellite instability in human hepatocellular carcinoma: relationship to p53 abnormalities. Liver (1998) 0.80
OKT3 rescue for steroid-resistant rejection in adult liver transplantation. Transplantation (1993) 0.79
Cytomegalovirus infection in orthotopic liver transplantation. Transpl Int (1989) 0.79
General guidelines for the use of tacrolimus in adult liver transplant patients. Transplantation (1996) 0.79
Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation (1998) 0.79
A new rat model for studies of the ischemic injury after transplantation of fatty livers: improvement after postoperative administration of prostaglandin. Transplantation (1994) 0.79
Use of anti-hepatitis C virus seropositive organs in liver transplantation. Transplant Proc (1995) 0.79